Instil Bio, Inc. (TIL) Stock Analysis & Investment Frameworks
Instil Bio, Inc. (TIL) stock analysis on Invetso. Review Instil Bio, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Instil Bio, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Instil Bio, Inc. Key Financial Metrics
- Market Cap: $39.13M
- Revenue: $N/A
- ROE: -26.78%
- ROIC: -18.61%
- Dividend Yield: N/A
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Instil Bio, Inc. Investment Frameworks
Invetso analyzes Instil Bio, Inc. (TIL) across the following frameworks:
- Instil Bio, Inc. 10Y Growth Potential
- Instil Bio, Inc. Scenario Analysis
- Instil Bio, Inc. Risks & Opportunities
- Instil Bio, Inc. Economic Moat
- Instil Bio, Inc. Business Model
- Instil Bio, Inc. Management
- Instil Bio, Inc. SWOT Analysis
- Instil Bio, Inc. Porter's 5 Forces
- Instil Bio, Inc. PESTLE Analysis
- Instil Bio, Inc. ESG Analysis